Literature DB >> 15794785

The assessment of patient life-expectancy: how accurate are urologists and oncologists?

James R M Wilson1, Michael G Clarke, Paul Ewings, John D Graham, Ruaraidh MacDonagh.   

Abstract

OBJECTIVE: To assess the degree of accuracy, precision and consistency with which consultant urologists, oncologists and junior doctors predict a patient's 10-year life-expectancy. SUBJECTS AND METHODS: Eighteen doctors of varying seniority independently examined 70 patient case scenarios containing detailed medical histories; 13 of these cases were duplicate scenarios. Bland-Altman analyses were used to compare doctors' estimates of the probability of each hypothetical patient surviving 10 years with that calculated using actuarial methods. Intra- and interdoctor reliability were also assessed.
RESULTS: Compared with actuarial estimates, doctors underestimated the 10-year survival probability by an overall mean of 10.8% (95% confidence interval, 10.1-11.5%). The 18 individual doctors ranged from a mean underestimation of 33.2% to a mean overestimation of 3.9%. Variation around these means was considerable for each doctor, the standard deviations being 14.5-20.9%. Inter-doctor reliability was 0.58, while overall intra-doctor reliability was 0.74, but for individual doctors was 0.31-0.94. Junior doctors were less accurate in their predictions than the senior doctors. Five doctors tended to overestimate where life-expectancy was poor and underestimate where it was good.
CONCLUSIONS: Doctors were poor at predicting 10-year survival, tending to underestimate when compared with actuarial estimates. There was also substantial variability both within and between doctors. The inaccuracy, imprecision and inconsistency amongst the doctors in assessing patient life-expectancy is an important finding and has significant implications for managing patients. Many patients may be denied treatment after a pessimistic assessment of life-expectancy and (less commonly) some may inappropriately be offered treatment after an optimistic assessment. The particular inaccuracy in junior doctors compared with their senior colleagues also highlights the need for training. The development of a tool to assist in both training and clinical practice has the potential to improve doctors' decision-making and patient care.

Entities:  

Mesh:

Year:  2005        PMID: 15794785     DOI: 10.1111/j.1464-410X.2005.05403.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  24 in total

1.  Remaining Life Expectancy Measurement and PSA Screening of Older Men.

Authors:  Ashwin A Kotwal; Supriya G Mohile; William Dale
Journal:  J Geriatr Oncol       Date:  2012-07-01       Impact factor: 3.599

2.  What rates of glaucoma progression are clinically significant?

Authors:  Luke J Saunders; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Expert Rev Ophthalmol       Date:  2016-05-13

3.  [Radical prostatectomy or watchful waiting in early prostate cancer?]

Authors:  Frank Zimmermann; Alexandros Papachristofilou
Journal:  Strahlenther Onkol       Date:  2019-11       Impact factor: 3.621

Review 4.  Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.

Authors:  Jesse D Sammon; Firas Abdollah; Anthony D'Amico; Matthew Gettman; Alexander Haese; Nazareno Suardi; Andrew Vickers; Quoc-Dien Trinh
Journal:  Eur Urol       Date:  2015-03-26       Impact factor: 20.096

5.  Prediction of mortality after radical prostatectomy by Charlson comorbidity index.

Authors:  Thomas J Guzzo; Paul Dluzniewski; Ryan Orosco; Elizabeth A Platz; Alan W Partin; Misop Han
Journal:  Urology       Date:  2010-09       Impact factor: 2.649

6.  The impact of preoperative erectile dysfunction on survival after radical prostatectomy.

Authors:  Misop Han; Bruce J Trock; Alan W Partin; Elizabeth B Humphreys; Trinity J Bivalacqua; Thomas J Guzzo; Patrick C Walsh
Journal:  BJU Int       Date:  2010-12       Impact factor: 5.588

7.  Impact of comorbidity on survival among men with localized prostate cancer.

Authors:  Peter C Albertsen; Dirk F Moore; Weichung Shih; Yong Lin; Hui Li; Grace L Lu-Yao
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

8.  Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management.

Authors:  Kevin M Y B Leung; Wilma M Hopman; Jun Kawakami
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

9.  [Value of cystoprostatectomy in locally advanced prostate carcinoma].

Authors:  N Zantl; J E Gschwend
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

10.  Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration.

Authors:  Ericka M Sohlberg; I-Chun Thomas; Jaden Yang; Kristopher Kapphahn; Timothy J Daskivich; Ted A Skolarus; Jeremy B Shelton; Danil V Makarov; Jonathan Bergman; Christine Ko Bang; Mary K Goldstein; Todd H Wagner; James D Brooks; Manisha Desai; John T Leppert
Journal:  Urol Oncol       Date:  2020-07-13       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.